The story of Viagra, and its developer copyright, presents a challenging case study for investors. At first a blockbuster drug, generating billions in sales , its intellectual property lapse created a wave of https://bookmarkstime.com/story22090846/sildenafil-and-big-pharma-a-risky-opportunity